News 
Market Data 
Discover
Steady_T
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
| Ticker | Board | News | Price | Change | Chg% | Added | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| NWBO | NorthWest Biotherapeutics Inc | 0.3189 | -0.0011 | -0.34% | 06/29/2024 | |||||
| AVXL | Anavex Life Sciences Corp | 5.64 | -0.12 | -2.08% | 02/07/2019 | |||||
|
My AVXL Pitch: They have a different approach to CNS diseases. Their Alzheimer's drug is in phase 2/3 trials in Australia. They have 2 other trials underway the drug. Rett syndrome and Parkinson's disease. If any of the trials is successful it will be a blockbuster since it will validate the new drug approach.
|
||||||||||
AI
